These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8403622)

  • 1. Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome.
    Mortola JF
    Clin Obstet Gynecol; 1993 Sep; 36(3):753-63. PubMed ID: 8403622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin.
    Mortola JF; Girton L; Fischer U
    J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
    Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
    Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenstrual syndrome. Tailoring treatment to symptoms.
    Nader S
    Postgrad Med; 1991 Jul; 90(1):173-80. PubMed ID: 1905806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al.
    Jungheim ES; Kenerson JJ; Foyouzi-Yousefi N; Allsworth JE; Marquard KL
    Am J Obstet Gynecol; 2009 Aug; 201(2):e1-5. PubMed ID: 19646561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
    Friedman AJ; Lobel SM; Rein MS; Barbieri RL
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic strategies for managing premenstrual syndrome.
    Moline ML
    Clin Pharm; 1993 Mar; 12(3):181-96. PubMed ID: 8491076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
    Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR
    N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
    Freeman EW; Sondheimer SJ; Rickels K; Albert J
    J Clin Psychiatry; 1993 May; 54(5):192-5. PubMed ID: 8509350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for add-back with gonadotrophin-releasing hormone agonist therapy.
    Studd J; Leather AT
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Add-back" therapy for endometriosis in adolescents.
    Lubianca JN; Gordon CM; Laufer MR
    J Reprod Med; 1998 Mar; 43(3):164-72. PubMed ID: 9564639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update.
    McLaren JS; Morris E; Rymer J
    Menopause Int; 2012 Jun; 18(2):68-72. PubMed ID: 22611225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.
    Mortola JF
    Drug Saf; 1994 Feb; 10(2):160-9. PubMed ID: 8011181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The premenstrual syndrome.
    Muse K
    Curr Opin Obstet Gynecol; 1991 Dec; 3(6):865-9. PubMed ID: 1818726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The premenstrual syndrome. Effects of "medical ovariectomy".
    Muse KN; Cetel NS; Futterman LA; Yen SC
    N Engl J Med; 1984 Nov; 311(21):1345-9. PubMed ID: 6387488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
    Surrey ES
    Fertil Steril; 1995 Oct; 64(4):673-85. PubMed ID: 7672133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.